{"id":"https://genegraph.clinicalgenome.org/r/31f36a41-d221-45e3-93a2-93bc0e3a847av1.4","type":"EvidenceStrengthAssertion","dc:description":"*PPT1* was first reported in relation to autosomal recessive neuronal ceroid lipofuscinosis (NCL) (MONDO:0016295) in 1998 (Mitchison et al., PMID: 9425237). Of note, NCL is also referred to as Batten disease and, in the case of NCL caused by variants in *PPT1*, ceroid lipofuscinosis, neuronal 1 (CLN1). NCL is a lysosomal storage disorder that is often characterized by intracellular accumulation of autofluorescent lipopigments and progressive neurodegeneration beginning in childhood, and can involve a variety of phenotypes including: seizures, cognitive decline, vision deterioration, blindness, and brain atrophy. Nine variants (missense, frameshift, nonsense, and intronic) that have been reported in 12 probands in three publications are included in this curation (PMIDs: 31741823, 19793312, 19302939). Of all variants described, one nonsense variant, p.Arg151*, has been reported to account for 40% of all known alleles (PMID: 9664077). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by animal models (PMIDs: 11717424, 31289301). In summary, there is definitive evidence supporting the relationship between *PPT1* and neuronal ceroid lipofuscinosis (MONDO:0016295). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. \n\nThis classification was originally approved by the ClinGen Epilepsy GCEP on the meeting date June 16, 2020 (SOP Version 7). As of March 30, 2023, this record underwent administrative updates. Evidence scoring was modified to reflect the new recommendations made in SOP Version 9. An evidence summary was also added. No new evidence was reviewed or added at that time. Most recently, on June 10, 2024, this record underwent further administrative updates to include the ClinGen Retina GCEP as a secondary contributor. Additional explanatory text was added to the evidence summary, but the original evidence was not changed.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/31f36a41-d221-45e3-93a2-93bc0e3a847a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:sopChange"}],"contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10072","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2024-06-10T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2024-06-10T15:40:58.095Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/986a25a1-3d0d-4572-b62b-602a31931b3b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4925ab7e-4f91-4aab-87c9-802f7474747c","type":"Finding","dc:description":"The model organisms displays spasticity, ataxia, hind-limb paralysis, aggressive behaviour, spontaneous seizures and enzyme deficiency. The human phenotype includes symptoms such as seizures, spasticity, and ataxia along with other neurological symptoms, as well as enzyme deficiency.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11717424","rdfs:label":"Knock-out PPT1 mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8e508146-58af-4f5e-a76f-fd2822fc3e82","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/447aced3-a2a3-4868-85d8-c35e95a1face","type":"Finding","dc:description":"Vision loss, early death in infancy, and reduced PPT1 activity is observed in human patients as well as in the model organism.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31289301","rdfs:label":"CRIPSR/CAS9 generated sheep","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ae7ebc05-9401-4932-afe2-a80e0d31e12f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d003e6e-5072-4693-bd95-f5d7a1fb041f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d003e6e-5072-4693-bd95-f5d7a1fb041f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","rdfs:label":"Simonati Patient 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.665T>C (p.Leu222Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263538"}},"detectionMethod":"Direct sequencing of the CLN1 gene was performed on polymerase chain reaction-amplified fragments.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001336","obo:HP_0001272","obo:HP_0002119","obo:HP_0001257","obo:HP_0001250","obo:HP_0012444"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e166bd65-8db8-41d7-a0b6-81b5b9e1b264_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e166bd65-8db8-41d7-a0b6-81b5b9e1b264","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e166bd65-8db8-41d7-a0b6-81b5b9e1b264_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e166bd65-8db8-41d7-a0b6-81b5b9e1b264_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased PPT1 activity noted in patient peripheral leukocytes.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6bf29d8a-f620-4419-9f0b-f4151aa1454b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bf29d8a-f620-4419-9f0b-f4151aa1454b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.451C>T (p.Arg151Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316936"}},{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.223A>C (p.Thr75Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254577"}}],"detectionMethod":"Applied Sanger sequencing to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10).","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000556","obo:HP_0002059","obo:HP_0001268","obo:HP_0001250"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/98e7af80-7940-4d70-bd67-b864c6d3ebac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/33109e7a-1fa4-4ec2-8468-a6b57df84dd5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/98e7af80-7940-4d70-bd67-b864c6d3ebac","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98e7af80-7940-4d70-bd67-b864c6d3ebac_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/33109e7a-1fa4-4ec2-8468-a6b57df84dd5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33109e7a-1fa4-4ec2-8468-a6b57df84dd5_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/f38d2268-9500-4539-bc1a-fea71c82fb03_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f38d2268-9500-4539-bc1a-fea71c82fb03","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 7","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a"},"detectionMethod":"Applied Sanger sequencing to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10)","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Granular osmiophilic profiles noted in skin biopsy.","phenotypes":["obo:HP_0000505","obo:HP_0001337","obo:HP_0000718","obo:HP_0002376"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/51c7fe9e-dfd6-439d-89e0-d123f013564b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/51c7fe9e-dfd6-439d-89e0-d123f013564b","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51c7fe9e-dfd6-439d-89e0-d123f013564b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c9e41ff8-005c-4a7c-9b9e-77ddf83a7f58_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9e41ff8-005c-4a7c-9b9e-77ddf83a7f58","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19793312","rdfs:label":"Kohan Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b"},{"id":"https://genegraph.clinicalgenome.org/r/725c144b-6a59-4da4-937d-ba296fbb1c2c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.363-3T>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263501"}}],"detectionMethod":"All exons and exonâ€“intron boundaries were amplified from whole-blood genomic DNA using intron-based primers.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002376","obo:HP_0001251","obo:HP_0001250"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0cf543ef-bdb1-480e-994c-9d249ebc384a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19793312","allele":{"id":"https://genegraph.clinicalgenome.org/r/725c144b-6a59-4da4-937d-ba296fbb1c2c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/cacd4806-4e91-441a-b053-ba6f4f8c216b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19793312","allele":{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0cf543ef-bdb1-480e-994c-9d249ebc384a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0cf543ef-bdb1-480e-994c-9d249ebc384a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0cf543ef-bdb1-480e-994c-9d249ebc384a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased PPT1 activity detected in leukocytes","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cacd4806-4e91-441a-b053-ba6f4f8c216b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cacd4806-4e91-441a-b053-ba6f4f8c216b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cacd4806-4e91-441a-b053-ba6f4f8c216b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased PPT1 activity detected in leukocytes","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/33d989ce-c72a-4edb-843d-44d757e0eb74_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33d989ce-c72a-4edb-843d-44d757e0eb74","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","rdfs:label":"Simonati Patient 5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3ad2b900-4b6d-4e9b-b80d-0d3eddec5cc3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.125-15T>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263471"}},"detectionMethod":"Direct sequencing of the CLN1 gene was performed on polymerase chain reaction-amplified fragments.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002376","obo:HP_0000505","obo:HP_0001250","obo:HP_0001336"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/52ebc870-0faf-4d53-a6a1-537c47470715_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ad2b900-4b6d-4e9b-b80d-0d3eddec5cc3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/52ebc870-0faf-4d53-a6a1-537c47470715","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52ebc870-0faf-4d53-a6a1-537c47470715_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/52ebc870-0faf-4d53-a6a1-537c47470715_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Low PPT1 activity observed in skin fibroblasts.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0e184d56-963a-4914-95b0-2867220822d1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e184d56-963a-4914-95b0-2867220822d1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/880b9536-611c-48b1-bfb7-8b3682262228","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.674T>C (p.Phe225Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263540"}},"detectionMethod":"Sanger sequencing applied to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10)","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001250","obo:HP_0002376","obo:HP_0001263"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1321a2b4-23fd-406c-93ae-4bb9f8a5361c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/880b9536-611c-48b1-bfb7-8b3682262228"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/1321a2b4-23fd-406c-93ae-4bb9f8a5361c","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1321a2b4-23fd-406c-93ae-4bb9f8a5361c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/91ea7087-4b03-43c8-9a49-b269615a4e1d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91ea7087-4b03-43c8-9a49-b269615a4e1d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","rdfs:label":"Simonati Patient 3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5"},"detectionMethod":"Direct sequencing of the CLN1 gene was performed on polymerase chain reaction-amplified fragments.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000718","obo:HP_0002376","obo:HP_0001336","obo:HP_0002487","obo:HP_0001250","obo:HP_0001257"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/172ba83b-e1b9-4578-9af9-fbb892af5cea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/172ba83b-e1b9-4578-9af9-fbb892af5cea","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/172ba83b-e1b9-4578-9af9-fbb892af5cea_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/172ba83b-e1b9-4578-9af9-fbb892af5cea_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased PPT1 activity in skin fibroblasts.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e2f60f92-1dd9-4375-a31f-63bc0a6383b2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2f60f92-1dd9-4375-a31f-63bc0a6383b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","rdfs:label":"Simonati Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5"},"detectionMethod":"Direct sequencing of the CLN1 gene was performed on polymerase chain reaction-amplified fragments","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002119","obo:HP_0000750","obo:HP_0001251","obo:HP_0001257","obo:HP_0000546","obo:HP_0001250"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/405e892c-cff7-4fc4-8f4f-f330d1eb7931_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19302939","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b548259-4a56-4402-b734-8181a72006c5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/405e892c-cff7-4fc4-8f4f-f330d1eb7931","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/405e892c-cff7-4fc4-8f4f-f330d1eb7931_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/405e892c-cff7-4fc4-8f4f-f330d1eb7931_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced PPT1 activity noted in skin fibroblasts.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ebceccc8-b3cc-4ebc-be5f-ce33ac451290_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebceccc8-b3cc-4ebc-be5f-ce33ac451290","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a"},"detectionMethod":"Applied Sanger sequencing to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10)","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Granular osmiophilic profiles noted in conjunctival biopsy","phenotypes":["obo:HP_0001268","obo:HP_0000738","obo:HP_0000510"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2acb8d1d-8ad7-464e-a0d3-61def7733112_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f8301c9-90a6-4114-8596-6426c4452c2a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/2acb8d1d-8ad7-464e-a0d3-61def7733112","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2acb8d1d-8ad7-464e-a0d3-61def7733112_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/5207087b-3f76-405e-8732-4cc78d8e28da_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5207087b-3f76-405e-8732-4cc78d8e28da","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7ca43dfa-7c77-4c85-a180-33c11f8f8f6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.29T>A (p.Leu10Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254584"}},{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b"}],"detectionMethod":"Applied Sanger sequencing to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10)","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001250","obo:HP_0002305","obo:HP_0100704","obo:HP_0001251","obo:HP_0001263"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e4982a0f-4cc5-4cb6-b232-fa31baf220b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/20e17b2c-d3f7-46b8-9eb4-46a18cd0961b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/692b1b23-2c39-4d1e-a763-2c2ba14c296f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ca43dfa-7c77-4c85-a180-33c11f8f8f6e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/e4982a0f-4cc5-4cb6-b232-fa31baf220b8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4982a0f-4cc5-4cb6-b232-fa31baf220b8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/692b1b23-2c39-4d1e-a763-2c2ba14c296f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/692b1b23-2c39-4d1e-a763-2c2ba14c296f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/93fe2865-12c5-4cd1-b78a-3b88e0edf8a4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93fe2865-12c5-4cd1-b78a-3b88e0edf8a4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","rdfs:label":"Jilani Patient 5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/853c3903-3892-4e99-9e8e-999b66da47a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.541G>C (p.Val181Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339847926"}},{"id":"https://genegraph.clinicalgenome.org/r/a4e91089-d98a-4df1-bfe1-3a36c7daf400","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000310.4(PPT1):c.289_290del (p.Gln97GlyfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA916082014"}}],"detectionMethod":"Applied Sanger sequencing to eight CLN genes (CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, CLN7, CLN8, CLN10)","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000648","obo:HP_0001276","obo:HP_0001272","obo:HP_0001263","obo:HP_0000518","obo:HP_0001250"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/698a9ce6-0261-41c0-b62b-db6e20fcf7b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/853c3903-3892-4e99-9e8e-999b66da47a4"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/0a505e0f-c419-4c3f-a8b5-97345c70b545_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31741823","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4e91089-d98a-4df1-bfe1-3a36c7daf400"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0a505e0f-c419-4c3f-a8b5-97345c70b545","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a505e0f-c419-4c3f-a8b5-97345c70b545_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/698a9ce6-0261-41c0-b62b-db6e20fcf7b9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/698a9ce6-0261-41c0-b62b-db6e20fcf7b9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8397,"specifiedBy":"GeneValidityCriteria10","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JZzX_XFdbF0","type":"GeneValidityProposition","disease":"obo:MONDO_0016295","gene":"hgnc:9325","modeOfInheritance":"obo:HP_0000007"},"version":"1.4","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ae7ebc05-9401-4932-afe2-a80e0d31e12f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}